Monkeypox Declared A Public Health Emergency

Monkeypox Declared a Public Health Emergency

Via Mercola

Story at-a-glance

• By the third week of July 2022, some 16,000 cases of monkeypox had been recorded across 75 countries, with the vast majority of cases occurring among homosexual and bisexual men. In the U.S., recorded cases were around 3,000, including two children
• 
  
• July 23, 2022, World Health Organization Director-General Tedros Adhanom Ghebreyesus unilaterally overruled this panel of advisers and declared monkeypox a “public health emergency of international concern” (PHEIC). Ghebreyesus made the decision to declare a PHEIC even though the WHO’s advisory panel opposed the declaration 9 to 6
• 
  
• According to Ghebreyesus, “for the moment this is an outbreak that is concentrated among men who have sex with men, especially those with multiple sexual partners. That means that this is an outbreak that can be stopped with the right strategies in the right groups”
• At present, the PHEIC appears to be financially motivated. Moderna is testing an mRNA injection for monkeypox, and in addition to the two smallpox vaccines already approved, Aventis Pasteur also has a smallpox vaccine that, while still investigational, could receive emergency use authorization
• 
  
• Disturbingly, in February 2022, the Wuhan Institute of Virology published a study in which they describe creating a portion of a monkeypox genome from scratch in order to develop a PCR test for monkeypox diagnosis. The National Institutes for Health in the U.S. also began studying a monkeypox drug in 2020

Ever since the first European cases of monkeypox were confirmed in early May 2022, many suspected smallpox or monkeypox would become the next global pandemic to justify continued tyranny and the World Economic Forum’s Great Reset.

Indeed, in early December 2021, media started signaling that smallpox might be the next pandemic. As it turns out, monkeypox1 is the same family as smallpox,2 but is nowhere nearly as lethal.

By the third week of July 2022, some 16,000 cases of monkeypox had been recorded across 75 countries, with the vast majority of cases occurring among homosexual and bisexual men. In the U.S., recorded cases were around 3,000, including two children.

As reported by The New York Times,3 as of late June 2022, World Health Organization advisers still did not recommend issuing an emergency declaration for smallpox, in large part because “the disease had not moved out of the primary risk group, men who have sex with men, to affect pregnant women, children or older adults, who are at greater risk of severe illness if they are infected.”

One month later, the panel was still deadlocked in disagreement, with six supporting a declaration and nine opposing it.4 Despite the lack of consensus, July 23, 2022, WHO Director-General Tedros Adhanom Ghebreyesus unilaterally overruled this panel of advisers and declared monkeypox a “public health emergency of international concern” (PHEIC).5

According to Ghebreyesus, six versus nine “is very, very close,” and “Since the role of the committee is to advise, I then had to act as a tie-breaker.”7 In the real world, six versus nine is not “a tie.” So, clearly, the director-general was driven to act based on something else, and this silly justification was all he could come up with.

Importantly, the “public health emergency of international concern” declaration gives Ghebreyesus a number of distinct powers, including the ability to recommend how member states should respond to the outbreak, which of course includes the recommendation to mass vaccinate. As reported by The New York Times:8

As discussed by Dr. John Campbell in the featured video, the Wuhan Institute of Virology (WIV) in China and the National Institutes of Health in the U.S. have coincidentally been working on the monkeypox virus and its treatment9 for some time.

The Wuhan Institute of Virology published a study in February 2022, in which they describe creating a portion of a monkeypox genome from scratch in order to develop a PCR test for monkeypox diagnosis.

The NIH, which has identified monkeypox as a potential bioterrorism agent, is currently studying the safety and efficacy of an antiviral called tecovirimat for the treatment of monkeypox. The study in question began September 28, 2020, and will run through the end of September 2025.

More...

More disappearing data